Incidence of Cobalamin, Iron, and Folate Deficiency Levels caused by Multiple MyelomaInto Diagnosed Patients. A Cross-Sectional Study

Micronutrient Status in Multiple Myeloma

Authors

  • Muhammad Ibrahim Tahir Lahore Medical & Dental College(LM&DC), Lahore, Pakistan Author
  • Amna Imran Al-Aleem Medical College, Lahore, Pakistan Author
  • Muhammad Talha Lahore Medical & Dental College (LM&DC), Lahore, Pakistan Author
  • Waleed Ahmad Lahore Medical & Dental College (LM&DC), Lahore, Pakistan Author
  • Mustafa Khalid Waheed Lahore Medical & Dental College (LM&DC), Lahore, Pakistan Author
  • Saleha Nadeem Al-Aleem Medical College, Lahore, Pakistan Author

DOI:

https://doi.org/10.69750/dmls.02.03.0108

Keywords:

Multiple myeloma, cobalamin deficiency, iron deficiency, folate, anemia, micronutrients

Abstract

Background: Plasma cell malignancy, known as multiple myeloma, can present with anemia. Micronutrient deficiencies, especially of cobalamin (vitamin B12), iron, and folate, can cause severe anemias, although, as a rule, anemia is attributed to marrow infiltration and renal dysfunction.

Objectives: The incidence of cobalamin, iron, and folate deficiencies in newly diagnosed and treatment-naive multiple myeloma patients and their correlation with baseline hematologic parameters were determined.

Methods: A total of 80 newly diagnosed multiple myeloma patients were included in this cross-sectional study. Before the start of therapy, the serum levels of vitamin B12, ferritin, transferrin saturation, and red cell folate were measured. Cobalamin deficiency cut-offs were defined as < 200 pg/mL (serum), < 30 ng/mL (ferritin) or < 20% (transferrin saturation), red cell folate < 150 ng/mL. SPSS Version 26 was used to compare hematologic parameters between deficient and non-deficient groups.

Results: The patients presented cobalamin deficiency in 37.5%, iron deficiency in 31.3%, and folate deficiency in 22.5%. About 56.3% had one or more deficiencies, and 15% had combined deficiencies. Specifically, patients with any deficiency had a mean hemoglobin (9.2 g/dL vs. 10.8 g/dL; p = 0.001) and mean corpuscular volume (95.1 fL vs. 88.3 fL; p < 0.001) significantly lower than those with no deficiencies.

Conclusion: Newly diagnosed multiple myeloma is associated with a very high prevalence of micronutrient deficiencies, particularly of cobalamin and iron, and deficiency anemia. A routine screening and correction of these deficiencies should be included as part of the initial evaluation to improve hematologic status and treatment outcomes.

Downloads

Download data is not yet available.

References

Oortgiesen BE, Kroes JA, Scholtens P, Hoogland J, Dannenberg - de Keijzer P, Siemes C, et al. High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study. Supportive Care in Cancer. 2022;30(1):271-8.doi: 10.1007/s00520-021-06414-3

Pandey A, Aryan R, Krishna M, Singh S, Pankaj P. Prevalence of iron and Vitamin B12 deficiencies and inflammatory anemia in treatment-naive patients with cancer: A cross-sectional study. Cancer Research, Statistics, and Treatment. 2020;3(4).doi: 10.4103/CRST.CRST_248_20

Esposito G, Dottori L, Pivetta G, Ligato I, Dilaghi E, Lahner E. Pernicious Anemia: The Hematological Presentation of a Multifaceted Disorder Caused by Cobalamin Deficiency. Nutrients [Internet]. 2022; 14(8).doi: 10.3390/nu14081672

Harini M, Vinod KV, Adole PS, Dubashi B. Elevated Serum Vitamin B12 Levels and Functional Vitamin B12 Deficiency among Patients with Myeloproliferative Neoplasms. Indian Journal of Hematology and Blood Transfusion. 2024.doi: 10.1007/s12288-024-01877-w

Gascón P, Arranz R, Bargay J, Ramos F. Fatigue- and health-related quality-of-life in anemic patients with lymphoma or multiple myeloma. Supportive Care in Cancer. 2018;26(4):1253-64.doi: 10.1007/s00520-017-3948-5

Greenfield DM, Boland E, Ezaydi Y, Ross RJM, Ahmedzai SH, Snowden JA, et al. Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma. Bone Marrow Transplantation. 2014;49(7):907-12.doi: 10.1038/bmt.2014.63

Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascón P, Glaspy J, et al. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. Annals of Oncology. 2018;29:iv96-iv110.doi: 10.1093/annonc/mdx758

Bhuyan A, Hazarika P, Deka R. Clinicopathological Features of Pancytopenia in Adults and the Role of Bone Marrow Study in Etiological Categorization: A One-Year Cross-Sectional Study. Medical Journal of Babylon. 2022;19(3):415-21.doi: 10.4103/mjbl.Mjbl_55_22

Devalia V, Hamilton MS, Molloy AM, the British Committee for Standards in H. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. British Journal of Haematology. 2014;166(4):496-513.doi: https://doi.org/10.1111/bjh.12959

Kadhiravan E, Devi A, Mohan R, Sindhuri R, Abdula S, Devi DSK. Anemia in Elderly Patients ≥65 Years of Age: a Hospital-based Cross-sectional Study. Journal of the Indian Academy of Geriatrics. 2023;19(1).

Ransing RS, Patil S, Pevekar K, Mishra K, Patil B. Unrecognized Prevalence of Macrocytosis among the Patients with First Episode of Psychosis and Depression. Indian Journal of Psychological Medicine. 2018;40(1):68-73.doi: 10.4103/IJPSYM.IJPSYM_139_17

Cuskelly GJ, Mooney KM, Young IS. Folate and vitamin B12: friendly or enemy nutrients for the elderly: Symposium on ‘Micronutrients through the life cycle’. Proceedings of the Nutrition Society. 2007;66(4):548-58.doi: 10.1017/S0029665107005873

Ye T, Liujin L, Liuqing G, and Liang M. Association Between Hemoglobin Levels and Osteoporosis in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Diabetes, Metabolic Syndrome and Obesity. 2022;15(null):2803-11.doi: 10.2147/DMSO.S382480

Carmel R, Green R, Rosenblatt DS, Watkins D. Update on Cobalamin, Folate, and Homocysteine. Hematology. 2003;2003(1):62-81.doi: 10.1182/asheducation-2003.1.62

Abu-Zahab ZA, Qureshi H, Adham GM, Elzefzafy WM, Zalam SS, Rehan AM, et al. Frequency of comorbid diseases with high serum Vitamin B12 levels in patients attending King Salman Medical City (KSAMC), at Madinah. Int J Health Sci (Qassim). 2025;19(1):15-21.doi,

Seegobin K, Maharaj S, Nelson G, Carlson J, Baldeo C, Jacob R. Rapid Onset of B12 Deficiency in the Setting of Worsening Multiple Myeloma: Correlations between B12 Deficiency and Multiple Myeloma. Case Rep Oncol Med. 2017;2017:6458676.doi: 10.1155/2017/6458676

Baz R, Alemany C, Green R, Hussein M. Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: A retrospective review. Cancer. 2004;101:790-5.doi: 10.1002/cncr.20441

Sobczyńska-Malefora A, Edgard D, Andrew M, R. AK, and Harrington DJ. Vitamin B12 status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls. Critical Reviews in Clinical Laboratory Sciences. 2021;58(6):399-429.doi: 10.1080/10408363.2021.1885339

Downloads

Crossmark - Check for Updates PlumX Metrics

Published

24-04-2025

How to Cite

Tahir, M. I., Imran, A. ., Talha, M., Ahmad, W. ., Waheed, M. K. ., & Nadeem, S. . (2025). Incidence of Cobalamin, Iron, and Folate Deficiency Levels caused by Multiple MyelomaInto Diagnosed Patients. A Cross-Sectional Study: Micronutrient Status in Multiple Myeloma. DEVELOPMENTAL MEDICO-LIFE-SCIENCES, 2(3), 5-12. https://doi.org/10.69750/dmls.02.03.0108

Share